CompletedNCT02782442
This study exists to understand how a guided support group holds up over time after the earliest research stage. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT00716755
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 50 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
WithdrawnNCT05140135
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Pennsylvania
- Condition
- Schizophrenia
CompletedNCT03133143
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
- Condition
- Schizophrenia
CompletedNCT03559426
This study exists to understand how symptom tracking and monitoring holds up over time after the earliest research stage. Researchers are trying to understand whether symptom tracking and monitoring can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University College, London
- Condition
- Schizophrenia
TerminatedNCT03507127
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Brown University
- Condition
- Schizophrenia
TerminatedNCT03149107
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Germany
- Sponsor
- University Hospital, Bonn
- Condition
- Schizophrenia
TerminatedNCT02746965
This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
CompletedNCT04592042
This study exists to understand how a guided support group holds up over time after the earliest research stage. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 17 Years to 65 Years
- Countries
- Germany
- Sponsor
- Philipps University Marburg
- Condition
- Schizophrenia
CompletedNCT04588129
This study exists to learn from real-world information that can show how the medication LB-102 fits into care. Researchers are trying to understand whether the medication LB-102 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT00448630
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Turkey
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Schizophrenia
TerminatedNCT00581243
This study exists to better understand the safety of the medication SLV-313 and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Global
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Condition
- Schizophrenia
CompletedNCT03465371
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Center for Social Innovation, Massachusetts
- Condition
- Schizophrenia
TerminatedNCT03838484
This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
WithdrawnNCT05119894
This study exists to better understand the safety of the medication Brexpiprazole and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Global
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Condition
- Schizophrenia
CompletedNCT03510741
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Pakistan
- Sponsor
- Pakistan Institute of Living and Learning
- Condition
- Schizophrenia
CompletedNCT04822883
This study exists to better understand the safety of the medication RL-007 and how manageable it feels in practice. Researchers are trying to understand whether the medication RL-007 can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Recognify Life Sciences
- Condition
- Schizophrenia
CompletedNCT05106309
This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Cerevel Therapeutics, LLC
- Condition
- Schizophrenia
CompletedNCT04510298
This study exists to compare options and see whether the medication SP-624 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SP-624 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Condition
- Schizophrenia
CompletedNCT03969589
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
CompletedNCT02069925
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02864576
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 28 Years to 60 Years
- Countries
- Spain
- Sponsor
- Parc de Salut Mar
- Condition
- Schizophrenia
CompletedNCT05320991
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Germany
- Sponsor
- University Hospital, Bonn
- Condition
- Schizophrenia
CompletedNCT05229484
This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- I-Shou University
- Condition
- Schizophrenia
CompletedNCT03699501
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Condition
- Schizophrenia